.jpg)
Summary
Cancer GenomiCs.nl (CGC.nl) was established on January 1, 2013 as a ‘Center of Excellence’ funded by a ten year, 30.7 M€ grant from the Netherlands Ministry of Education, Culture and Science (NWO Gravitation Program). CGC.nl is a consortium of research groups from the University Medical Centre Utrecht, the Hubrecht Institute in Utrecht, Utrecht University, the Netherlands Cancer Institute in Amsterdam, the Erasmus Medical Centre in Rotterdam, the Academic Medical Center Amsterdam, Leiden University Medical Centre and Radboud University Medical Center Nijmegen.
Click here to download our flyer 'Identifying new approaches for cancer treatment'.
News
12 Jan 2018
annual CGC meeting 2018
All CGC.nl researchers are welcome, however registration is required.
28 Nov 2017
ERC grant for Michiel Vermeulen
Michiel Vermeulen, one of our CGC group leaders, was awarded a prestigious ERC-Consolidator Grant.
Read more >17 Nov 2017
Fumagalli wins CGC poster prize
Arianna Fumagalli received the 2017 poster award during the CGC meeting New Horizons in Cancer Research
Read more >Agenda
10 & 11 Jan 2019
CGC-Oncode annual scientific meeting
Annual meeting for the CGC and Oncode scientific community
08 & 09 Nov 2018
CGC-Oncode annual conference
Oncode and the Cancer Genomics Centre are pleased to host our annual joint scientific meeting at the KIT Royal Tropical Institute in Amsterdam. This year's topic is “From tissues to cells to molecules: multi-scale visualization of cancer processes”. More information is available here
05 Oct 2018
MASSterclass: Spectrometry & Cytometry
By Michiel Vermeulen and Yvonne Vercoulen Oncode Institute and CGC host a workshop about quantitative mass spectrometry-based proteomics and mass cytometry. What do you need to run a smooth experiment? Which kind of research questions can be answered? What are the costs? By the end of the workshop you will know what is needed to execute a succesful mass spectrometry or cytometry experiment. Please register here
Publications
CGC.nl flyer 2013 'Identifying new approaches for cancer treatment'
Extensive genetic and molecular research into the origins of cancer has made it clear that cancer results from multiple genetic defects and that these defects show great variation between patients.
Read more >
CBG report 1998-2009 'Exploring Genes: a decade of biomedical research'
The CBG provides each of the participating groups with funds for innovations and rapid responses to new technological developments and, importantly, it generates expertise and provides facilities that are accessible for a broader group of researchers in the Netherlands.
Read more >
Congresboek KGMP 2009 'Genenpaspoort van kanker: betere kansen voor de patient'
Genenpaspoort van kanker: betere kansen voor de patie¨nt. De laatste ontwikkelingen in kankeronderzoek.
Read more >